The terms eczema and dermatitis are used interchangeably to indicate a polymorphic inflammatory reaction that affects the epidermis and dermis. There are several causes and a wide variety of clinical manifestations.
Acute eczema/dermatitis is characterised by pruritus, erythema and vesicle formation; chronic eczema/dermatitis is characterised by pruritus, xerosis, lichenification, hyperkeratosis/scaling and fissures.
Therapeutic indications: Local treatment of inflammatory and pruritic manifestations of dermatoses that respond to corticosteroids, such as allergic and irritant contact dermatitis, nummular eczema and dyshidrotic eczema.
Celecrem cream is indicated in adults and children over 12 years of age.
Composition: Betamethasone 0.5 mg. (0.61 mg of betamethasone valerate)
Format: Tubes containing 30 grams or 60 grams of cream
Therapeutic indications: Local treatment of inflammatory manifestations of dermatoses that respond to corticosteroids in complicated cases with mixed infection caused by microorganisms that are sensitive to the components of the medicine.
Composition: 1 g of cream contains: Betamethasone (as valerate) 0.5 mg (0.61 mg betamethasone valerate), Gentamicin (as sulfate) 1 mg, Tolnaftate 10 mg, Clioquinol 10 mg.
Format: Cuatrocrem® Cream - 15 g
Cuatrocrem® Cream - 30 g
The contents of this section are strictly directed to health professionals with practice in Spain and certified to prescribe pharmaceutical products, which require specialized training for their right interpretation. Please notice that pharmaceutical products might have a different summary of characteristics authorised in other countries.
If you click 'accept' you are acknowledging you are willing to access information targeting health professionals.